Dermamedika - Company finances
|
EUR
|
2019
From: 2019-05-13
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 6,690 | 45,290 | 94,522 | 123,151 | 140,882 | 182,758 | 194,550 |
| Profit before tax | - | - | - | - | - | - | - |
| Net profit | -327 | 6,835 | 1,422 | 11,441 | 14,201 | 33,228 | 45,626 |
| Equity | 2,173 | 9,007 | 10,430 | 21,871 | 36,073 | 69,301 | 116,997 |
| Liabilities | 9,483 | 14,046 | 15,660 | 63,869 | 82,201 | 28,714 | 44,952 |
| Non-current assets | 9,440 | 9,269 | 948 | 55,783 | 90,462 | 81,454 | 133,236 |
| Current assets | 2,148 | 13,011 | 24,608 | 29,425 | 27,299 | 16,098 | 27,012 |
| Total assets | 11,588 | 22,280 | 25,556 | 85,208 | 117,761 | 97,552 | 160,248 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 24,385 | 31,531 | 27,318 |
| Social insurance contributions | - | - | - | - | 12,246 | 16,092 | 14,681 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +577.0% | +108.7% | +30.3% | +14.4% | +29.7% | +6.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -2.8% | 30.7% | 5.6% | 13.4% | 12.1% | 34.1% | 28.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -15.0% | 75.9% | 13.6% | 52.3% | 39.4% | 47.9% | 39.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -4.9% | 15.1% | 1.5% | 9.3% | 10.1% | 18.2% | 23.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 4.4 | 1.6 | 1.5 | 2.9 | 2.3 | 0.4 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 2,230 | 12,639 | 23,631 | 30,788 | 35,221 | 33,740 | 32,425 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dermamedika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-02-18 | 2025-03-04 | 1.55 |
| 2025-02-10 | 2025-02-10 | 1.55 |
| 2025-01-22 | 2025-02-06 | 1.55 |
| 2024-11-18 | 2024-11-19 | 1149.10 |
Dermamedika - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dermamedika, UAB (code 305159575) is a Private Limited Liability Company operating in medical specialists activities. In 2025, the company generated revenue of €194.6K and net profit of €45.6K, with a profit margin of 23.5%. Revenue increased by 6.5% year on year and by 38.1% over two years, showing a steady expansion trend. The revenue base rose from €140.9K in 2023 to €182.8K in 2024 and €194.6K in 2025, while net profit improved from €14.2K to €33.2K and then to €45.6K over the same period. At year-end 2025, total assets stood at €160.2K, equity at €117.0K and liabilities at €45.0K. The equity ratio was 73.0% and debt-to-equity 0.38, indicating a solid capital structure. Asset turnover was 1.21x, ROE was 39.0% and ROA 28.5%. Revenue per employee reached €32.4K, with profit per employee of €7.6K.